Bateman Nicholas W, Tan Dongfeng, Pestell Richard G, Black Jennifer D, Black Adrian R
Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Elm & Carlton Streets, Buffalo, NY 14263, USA.
J Biol Chem. 2004 Mar 26;279(13):12093-101. doi: 10.1074/jbc.M311532200. Epub 2004 Jan 15.
Krüppel-like transcription factors have been linked to cell growth regulation and tumorigenesis in a number of systems. In the intestinal epithelium, expression of KLF5 (IKLF/BTEB2) is limited to proliferating crypt cells, indicating a growth-promoting role. Consistent with this role, we demonstrate that expression of KLF5 in non-transformed intestinal epithelial cells (ileal IEC-18 and Immorto-Min Colon Epithelial (IMCE) cells) enhances colony formation, cyclin D1 transcription, and cell growth. However, in contrast to these effects in non-transformed cells, KLF5 reduced colony number, failed to enhance cyclin D1 transcription, and was negatively correlated with cell growth in colon cancer cell lines. The relationship between tumor progression and KLF5 was further investigated using Ras-mediated transformation of IEC-18 and IMCE cells as syngeneic models. Ras-transformation recapitulated differences in the effects of KLF5 on cell growth and cyclin D1 transcription, providing a direct link between intestinal tumor progression and altered function of KLF5. Ras-transformation also markedly down-regulated KLF5; further analysis indicated that reduced expression of KLF5 mRNA and destabilization of KLF5 protein occur in intestinal tumors. Reduced levels of KLF5 mRNA were also detected in APC(min) mouse and human familial adenomatous polyposis adenomas compared with normal crypt epithelium, indicating that down-regulation of KLF5 is an early event in intestinal tumorigenesis in vivo. Collectively, these data indicate that intestinal tumor progression is associated with a change in the growth-related functions of KLF5 and that intestinal tumors down-regulate KLF5 expression by multiple mechanisms.
Krüppel样转录因子在许多系统中都与细胞生长调节和肿瘤发生有关。在肠道上皮中,KLF5(IKLF/BTEB2)的表达仅限于增殖的隐窝细胞,表明其具有促进生长的作用。与这一作用一致,我们证明在未转化的肠道上皮细胞(回肠IEC-18和永生小鼠结肠上皮(IMCE)细胞)中KLF5的表达增强了集落形成、细胞周期蛋白D1转录和细胞生长。然而,与在未转化细胞中的这些作用相反,KLF5减少了结肠癌细胞系中的集落数量,未能增强细胞周期蛋白D1转录,并且与细胞生长呈负相关。使用Ras介导的IEC-18和IMCE细胞转化作为同基因模型,进一步研究了肿瘤进展与KLF5之间的关系。Ras转化概括了KLF5对细胞生长和细胞周期蛋白D1转录影响的差异,为肠道肿瘤进展与KLF5功能改变之间提供了直接联系。Ras转化还显著下调了KLF5;进一步分析表明,肠道肿瘤中发生了KLF5 mRNA表达降低和KLF5蛋白不稳定。与正常隐窝上皮相比,在APC(min)小鼠和人类家族性腺瘤性息肉病腺瘤中也检测到KLF5 mRNA水平降低,表明KLF5下调是体内肠道肿瘤发生的早期事件。总体而言,这些数据表明肠道肿瘤进展与KLF5生长相关功能的变化有关,并且肠道肿瘤通过多种机制下调KLF5表达。